| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.077 | 0.08 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |